Asia
Cambridge, Massachusetts-based Carmine Therapeutics inked a research collaboration deal with Japan’s Takeda Pharmaceutical to develop and commercialize non-viral gene therapies for two rare diseases.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 1, 2020.
Biopharma and life sciences companies bolster their executive teams and board with these Movers & Shakers.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
The companies will work to discover, develop and commercialize novel therapies that modulate G protein-coupled receptor (GPCR) targets that AbbVie selects.
Biopharma and life sciences companies provide updates on their pipelines and business plans.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 24, 2020.
The diagnostic tool will use Thermo Fisher’s next-generation sequencing (NGS)-based Oncomine Dx Target Test to identify HER2 (human epidermal growth factor receptor 2) gene mutations.
Crysvita is a drug developed by Ultragenyx Pharmaceutical and Tokyo-based Kyowa Kirin Co. Ltd., a specialty pharmaceutical company.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.
PRESS RELEASES